In 2019, a study examined the concentration of zinc-α2-glycoprotein (ZAG) in women with PCOS, its correlation with endocrine and metabolic indicators of women with PCOS, and the variations in ZAG levels after exenatide or metformin treatment (64). The gene discussed is AZGP1; the disease is polycystic ovary syndrome.